2018
DOI: 10.4103/jfmpc.jfmpc_330_17
|View full text |Cite
|
Sign up to set email alerts
|

Hyperacute liver injury following intravenous fluconazole: A rare case of dose-independent hepatotoxicity

Abstract: Fluconazole is a triazole antifungal medication used in the treatment of various fungal infections. It is available in both oral and parenteral formulations. Liver damage has been reported with fluconazole use, but most commonly it is benign elevated liver transaminases. Acute liver failure (ALF) in fluconazole use is rare, with cases being reported sporadically in literature and large cohorts describing incidence rates of acute liver injury ranging from 0.0 to 31.6/10,000 patients. We present a case of a 45-y… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 10 publications
0
11
0
Order By: Relevance
“…The pharmacokinetics, AE profile and potential drug-drug interactions of the three oral antifungal agents, terbinafine, itraconazole and fluconazole are summarized in Table 4. 83,89,90,94,100,101,[169][170][171][172][173][174][175][176][177] . Concentrations of systemic antifungal treatments persist for several months in the nails, which is beneficial as the drug can continue to exert its effects even after treatment has ended.…”
Section: Comparison Between Systemic Drugsmentioning
confidence: 99%
See 1 more Smart Citation
“…The pharmacokinetics, AE profile and potential drug-drug interactions of the three oral antifungal agents, terbinafine, itraconazole and fluconazole are summarized in Table 4. 83,89,90,94,100,101,[169][170][171][172][173][174][175][176][177] . Concentrations of systemic antifungal treatments persist for several months in the nails, which is beneficial as the drug can continue to exert its effects even after treatment has ended.…”
Section: Comparison Between Systemic Drugsmentioning
confidence: 99%
“…The pharmacokinetics, AE profile and potential drug–drug interactions of the three oral antifungal agents, terbinafine, itraconazole and fluconazole are summarized in Table 4 83,89,90,94,100,101,169–177 …”
Section: Pharmacokinetics Adverse Effects and Potential Drug–drug Inmentioning
confidence: 99%
“…The most common offending drugs are acetaminophen, nonsteroidal anti-inflammatory drugs, isoniazid, and amoxicillin/clavulanate [28]. However, there are several potential hepatotoxic agents of DILI leading to ALF [29][30][31].…”
Section: Molecular Adsorbent Recirculating System (Mars)mentioning
confidence: 99%
“…Only a small proportion of fluconazole is processed by the liver and about 60-80% is eliminated from the body by the renal system [12]. Nevertheless, there are several reports of fluconazole induced hepatic and kidney toxicity [13,14]. According to recent information, the pre-existing liver toxicity is further complicated by the antifungal use of fluconazole [15].…”
Section: Introductionmentioning
confidence: 99%